Cargando…

Aspects of Non-Pharmacological Treatment in Peripheral Arterial Disease

Detalles Bibliográficos
Autores principales:	Alves, Maria Janieire de N. Nunes, de Souza, Francis Ribeiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Cardiologia - SBC 2019
Materias:	Short Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6882388/ https://www.ncbi.nlm.nih.gov/pubmed/31621782 http://dx.doi.org/10.5935/abc.20190208

Ejemplares similares

Characteristics and Adverse Events in Acute Coronary Syndrome Patients with a History of Peripheral Arterial Disease
por: Castro, Iran, et al.
Publicado: (2019)

Can Non-Pharmacological Treatment Promote Additional Benefit for Children with Familial Hypercholesterolemia Treated with Statins?
por: Antoniazzi, Luiza
Publicado: (2018)

Elucidation of the Diagnosis and Treatment of Peripheral Arterial Disease
por: Kim, Hyung Oh, et al.
Publicado: (2018)

Secondary Dyslipidemia In Obese Children - Is There Evidence For Pharmacological Treatment?
por: Tanaka, Ana Cristina Sayuri
Publicado: (2018)

Modulation of Oxidative Stress: Pharmaceutical and Pharmacological Aspects
por: Korkina, Liudmila, et al.
Publicado: (2016)

Modulators of Oxidative Stress: Chemical and Pharmacological Aspects
por: Saso, Luciano, et al.
Publicado: (2020)

Feasibility of physiological pacing rate in cardiac resynchronization therapy
por: Spaggiari, Caio V., et al.
Publicado: (2023)

Physiological and pharmacologic aspects of peripheral nerve blocks
por: Vadhanan, Prasanna, et al.
Publicado: (2015)

The Search for New Prognosis Markers for Coronary Artery Disease
por: Pereira, Filipe Welson Leal, et al.
Publicado: (2019)

Modulation of Oxidative Stress: Pharmaceutical and Pharmacological Aspects 2017
por: Saso, Luciano, et al.
Publicado: (2017)

Modulation of Oxidative Stress: Pharmaceutical and Pharmacological Aspects 2018
por: Smith, Robert E., et al.
Publicado: (2019)

Pharmaceutical and Pharmacological Aspects of Modulation of Oxidative Stress 2020
por: Saso, Luciano, et al.
Publicado: (2022)

Cardiac and peripheral autonomic control in restrictive cardiomyopathy
por: Sayegh, Ana Luiza C., et al.
Publicado: (2017)

Non-Pharmacological Treatment of Cardiovascular Disease | Importance of Physical Exercise
por: Gomes, Mariana Janini, et al.
Publicado: (2019)

Peripheral arterial disease in polymyalgia rheumatica
por: Borg, Frances A, et al.
Publicado: (2009)

The effect of pharmacological treatment on gait biomechanics in peripheral arterial disease patients
por: Huisinga, Jessie M, et al.
Publicado: (2010)

The Ever‐Humbling Challenge of Peripheral Artery Disease Treatment Seen Across the Sexes
por: Braun, Jonathan D., et al.
Publicado: (2019)

Hypertension: Pathophysiological Aspects, Psychosocial Stress and Food Preference
por: Lopes, Heno Ferreira
Publicado: (2019)

Genetic Risk in Coronary Artery Disease
por: Martinez, Paula F., et al.
Publicado: (2018)

Co-occurrence of Cardiometabolic Disease Risk Factors: Unhealthy Eating, Tobacco, Alcohol, Sedentary Lifestyle and Socioeconomic Aspects
por: Eduard, Maury-Sintjago, et al.
Publicado: (2019)

“Obesity and Lean Paradox” in Peripheral Artery Disease
por: Lee, Seung Hun, et al.
Publicado: (2021)

Drug repurposing for the treatment of COVID-19: Pharmacological aspects and synthetic approaches
por: Batalha, Pedro N., et al.
Publicado: (2021)

Discriminating sarcopenia in overweight/obese male patients with heart failure: the influence of body mass index
por: Fonseca, G.W.P.D., et al.
Publicado: (2019)

Pharmacological aspects of galantamine for the treatment of Alzheimer's disease
por: Kim, Jae Kwang, et al.
Publicado: (2017)

Economic Burden of Cardiovascular Diseases in Brazil: Are Telemedicine and Structured Telephone Support the Solution?
por: da Silva, Suzana Alves, et al.
Publicado: (2018)

Health promotion or pharmacological treatment for chronic diseases?
por: ALLAM, M.F., et al.
Publicado: (2013)

Low serum magnesium as a risk factor for peripheral artery disease in chronic kidney disease: an open verdict
por: de Borst, Martin H, et al.
Publicado: (2020)

A Decade of Drug-Eluting Technology in Peripheral Arterial Disease: Blurred by Dissembling Evidence
por: Reekers, J. A., et al.
Publicado: (2016)

Thrombosis and Aspirin: Clinical Aspect, Aspirin in Cardiology, Aspirin in Neurology, and Pharmacology of Aspirin
por: Doutremepuich, Christian
Publicado: (2012)

Correlation between mesenteric fat thickness and serum apolipoproteins in patients with peripheral arterial occlusive disease
por: Perelas, Apostolos, et al.
Publicado: (2012)

Cardiovascular Rehabilitation in Coronary Artery Disease and Better Knowledge of Its Own Disease
por: César, Luiz Antonio Machado
Publicado: (2019)

Chemical and Pharmacological Aspects of Capsaicin
por: Reyes-Escogido, Maria de Lourdes, et al.
Publicado: (2011)

PPARβ/δ: Benefits in Coronary Artery Disease and Beyond
por: Leal, Viviane O.
Publicado: (2019)

Systems Pharmacology of VEGF165b in Peripheral Artery Disease
por: Clegg, Lindsay E., et al.
Publicado: (2017)

The Need for Translational Research to Advance Peripheral Artery Disease Management
por: Moxon, Joseph V., et al.
Publicado: (2015)

Clinical Decision Support for Peripheral Artery Disease: Answering the Call
por: Monteleone, Peter P., et al.
Publicado: (2018)

A new era of medical therapy for peripheral artery disease
por: Casella, Ivan Benaduce, et al.
Publicado: (2020)

A New Rodent Model of Non-Alcoholic Steatohepatitis and Metabolic Syndrome
por: Romeiro, Fernando Gomes, et al.
Publicado: (2019)

Coronary Artery Dilation in Children with Febrile Exanthematous Illness without Criteria for Kawasaki Disease -An Enigmatic Disease
por: Guerra, Vitor Coimbra
Publicado: (2019)

Non-pharmacological and non-psychological approaches to the treatment of PTSD: results of a systematic review and meta-analyses
por: Bisson, Jonathan I., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_q2f2fkg304tkmeob3o6ogqs5fj